Company intelligence / Profile preview

Curonix

Pompano Beach, Florida, United States

Ownership: Private
Development stage: Other

Overview

Curonix commercializes the Freedom PNS (Peripheral Nerve Stimulator) System, which is FDA-cleared for full-body use, including craniofacial indications. Multiple independent and retrospective studies report significant pain reduction, improved patient functionality, and medication reduction using the Freedom PNS System and HF-EMC technology. The company has expanded MR conditional labeling, allowing for safe MRI scans at both 1.5T and 3T throughout the body in patients with the device.

Therapeutic areas: OncologyNeurologyRheumatology
Modalities: DeviceNeurostimulator
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Curonix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Curonix.

Explore the full profile